XML 36 R25.htm IDEA: XBRL DOCUMENT
v3.26.1

Cash and Marketable Securities (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Cash and Cash Equivalents [Abstract] |
Summary of Cash and Cash Equivalents | A reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the amount reported within the condensed consolidated statements of cash flows is shown in the table below (in thousands):
| March 31, 2026 |  | March 31, 2025
Cash and cash equivalents | $ | 77,923 |  |  | $ | 88,745 |
Restricted cash | 551 |  |  | 550 |
Total cash, cash equivalents and restricted cash at the end of the period | $ | 78,474 |  |  | $ | 89,295 |
Summary of Restricted Cash | A reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets to the amount reported within the condensed consolidated statements of cash flows is shown in the table below (in thousands):
| March 31, 2026 |  | March 31, 2025
Cash and cash equivalents | $ | 77,923 |  |  | $ | 88,745 |
Restricted cash | 551 |  |  | 550 |
Total cash, cash equivalents and restricted cash at the end of the period | $ | 78,474 |  |  | $ | 89,295 |
Summary of Marketable Securities | The amortized cost, unrealized holding gains and losses and fair value of the Company’s marketable securities by major security type at each balance sheet date are summarized in the tables below (in thousands):
| March 31, 2026
| Amortized Cost |  | Unrealized Holding Losses |  | Fair Value
Marketable securities: |  |  |  |  |
U.S. agency securities | $ | 73,696 |  |  | $ | (48) |  |  | $ | 73,648 |
Corporate debt securities | 46,458 |  |  | (99) |  |  | 46,359 |
Total marketable securities | $ | 120,154 |  |  | $ | (147) |  |  | $ | 120,007 |
| December 31, 2025
| Amortized Cost |  | Unrealized Holding Gains |  | Fair Value
Marketable securities: |  |  |  |  |
U.S. agency securities | $ | 81,196 |  |  | $ | 595 |  |  | $ | 81,791 |
Corporate debt securities | 54,748 |  |  | 57 |  |  | 54,805 |
Total marketable securities | $ | 135,944 |  |  | $ | 652 |  |  | $ | 136,596 |

X
- References No definition available. + Details
Name: | us-gaap_CashAndCashEquivalentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets. + References No definition available. + Details
Name: | us-gaap_MarketableSecuritiesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of cash and cash equivalents. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(1)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 8 -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8 + Details
Name: | us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration